Expansion of the Priority Review Voucher Program Under the 21st Century Cures Act: Implications for Innovation and Public Health

Expansion of the Priority Review Voucher Program Under the 21^st Century Cures Act: Implications for Innovation and Public Health

Am J Law Med. 2018 May;44(2-3):329-341. doi: 10.1177/0098858818789430.

¹ M.D., J.D., M.P.H, Postdoctoral Fellow, Program On Regulation, Therapeutics, And Law ("PORTAL"), Brigham Women's Hospital and Research Fellow, Harvard Medical School, Boston, MA.
² M.D., M.B.A., M.Sc., Internal Medicine Resident, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
³ A.B., Researcher, PORTAL, Brigham and Women's Hospital, Boston, MA.
⁴ M.D., J.D., M.P.H., Associate Professor of Medicine, Harvard Medical School and Director, PORTAL, Brigham and Women's Hospital, Boston, MA. The work at PORTAL is supported by the Laura and John Arnold Foundation, with additional support from the Engelberg Foundation and the Harvard Program in Therapeutic Science.

No abstract available